Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitors-Reference-Cited by-同舟云学术

Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitors

Published:2018-06 Issue: Volume:154 Page:101-109
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Oyallon Bruno,Brachet-Botineau Marie,Logé Cédric,Bonnet Pascal,Souab Mohamed,Robert Thomas,Ruchaud Sandrine,Bach Stéphane,Berthelot Pascal,Gouilleux Fabrice,Viaud-Massuard Marie-Claude,Denevault-Sabourin Caroline

Funder

ADRINORD

ICOA/CBM

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference36 articles.

1. Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region;Cuypers;Cell,1984

2. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway;Mochizuki;J. Biol. Chem.,1999

3. The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C, Int;Bachmann;J. Biochem. Cell Biol.,2006

4. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias;Amson;Proc. Natl. Acad. Sci. U. S. A,1989

5. Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study;Hsi;Leuk. Lymphoma,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quinoxaline derivatives: Recent discoveries and development strategies towards anticancer agents;European Journal of Medicinal Chemistry;2024-05

2. Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer;Molecular Diversity;2024-04-20

3. Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and Obstacles;Journal of Medicinal Chemistry;2024-01-02

4. Proviral integration site for Moloney murine leukemia virus-1 (PIM-1) kinase inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

5. Potassium 6-Oxo-7,13,16,22-tetraazatetracyclo[12.6.2.18,12.017,21]tricosa-1(20),8(23),9,11,14,16,18,21-octaen-2-yne-15-carboxylate;Molbank;2023-10-09